Leon-Nanodrugs GmbH

https://www.leon-nanodrugs.com

Twitter: @leonnanodrugs

LinkedIn: https://www.linkedin.com/company/leon-nanodrugs

leon-nanodrugs GmbH (based in Munich) is a nanotechnology-based drug development company focused on reformulations and reinventions of drugs on a contract or co-development basis. Based on its “network of expertise”, leon-nanodrugs can provide a 360 degree service range – from concept to product approval. The core business is the reformulations to develop novel oral and parenteral formulations and innovative drug combinations, which have not been possible in the past due to low bioavailability caused by low solubility of APIs. The 2014 CPhI Pharma Awards for Best Innovation in Formulation was won by MJR PharmJet GmbH, leon nanodrugs’ exclusive reformulation service partner for its patented nanotechnology. *

	Start	2010-10-14 established
	Industry	drug delivery technology (drug formulation technology)
	Industry 2	nanoparticle technology

	Region	München (Munich)
	Country	Germany
	Street	Kopernikusstr.
	City	81679 München
	Tel	+49-89-41424889-0
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Leon-Nanodrugs GmbH. (7/27/15). "Press Release: Leon-Nanodrugs GmbH Raises EUR 18.5 Million in Series A Financing. TVM Capital Life Science Leads International Syndicate of Investors". Munich.

		Record changed: 2020-04-16